Nachrichten zur Merck & Co. Inc. Aktie

Dividend Roundup: Merck, TD Bank, Kohl’s, Haliburton, and more

…

Merck & Co., Inc. (MRK) Management Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)

…

Subdermal Contraceptive Implants Market revenue to reach USD 3 Billion by 2036, says Research Nester

Major subdermal contraceptive implants market players include Merck & Co., Inc., Shanghai Dahua Pharmaceutical Co., Ltd, Bayer AG, Wyeth Pharmaceuticals,…

Merck & Co: All I Want for Christmas is Keytruda - Aktienanalyse

Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Mercks (MRK) Pneumococcal Jab Shows Upbeat Responses in Study

Positive data from Mercks (MRK) phase III study on V116, an investigational, 21-valent pneumococcal conjugate vaccine, supports the immunogenicity of…

Merck raises dividend by 5.5% to $0.77

…

Coherus cancer drug undercuts Mercks Keytruda

…

: Merck raises quarterly dividend to 77 cents vs. 73 cents

Merck & Co. Inc. MRK said Tuesday its board has raised its quarterly dividend to 77 cents. The dividend was…

DZ BANK stuft MERCK KGAA auf Halten

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat Merck KGaA von "Kaufen" auf "Halten" abgestuft und den fairen Wert von…

Synthetic Hormones Market Analysis Report 2023-2033, Featuring Profiles of Eli Lilly, Pfizer, Ferring, Merck, Novo Nordisk, Bayer, Novartis and More

Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Synthetic Hormones Market: Focus on Product Type, Application, Route…

Global Glaucoma Treatment Market Size To Grow USD 10.5 Billion by 2032 | CAGR of 5.0%

The Global Glaucoma Treatment Market Size was valued at USD 6.4 Billion in 2022 and the Worldwide Glaucoma Treatment Market…

Merck Will Keep Your Retirement Income Healthy

…

Merck: Not The Time To Be Adding

…

Merck: Keytruda Patent Expiry Nears With Replacement Yet To Be Found

…

Oncology Drug Discovery & Development Market Expected to Grow at a CAGR of 18.2% from 2023 to 2031 | Reveals InsightAce Study

Companies covered in this study are Novartis, AstraZeneca, Merck & Co., Inc, Bristol-Myers Squibb, Pfizer, Eli Lilly and Company, Gilead…

DAX in Schlagdistanz zu 16.000 – Allianz, Fresenius, Merck, Rheinmetall, Siemens Energy und Siemens Health im Check

Sowohl die Fed Minutes als auch die Nvidia-Zahlen werden den deutschen Aktienmarkt werden den deutschen Aktienmarkt heute kaum tangieren. Die…

Merck (MRK) to Acquire Private Neuroscience Company for $610M

Merck (MRK) has been a shareholder in Caraway Therapeutics since 2018 through its MRL Ventures Fund.…

Merck to acquire Caraway Therapeutics for up to $610M

Merck & Co Inc announced on Tuesday an agreement to acquire Caraway Therapeutics Inc for a total potential consideration of up…

: Merck paying $610 million for Caraway Therapeutics

Merck & Co. Inc. MRK said Tuesday it agreed to pay up to $610 million to acquire Caraway Therapeutics, a…

Merck: A Dividend Growth Stock Worth Considering

…

Merck: Charttechnisch hochspannend - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Merck-Aktienanalyse von "Der Aktionär": Thomas Bergmann vom Anlegermagazin "Der Aktionär" nimmt im "Der Aktionär TV" die Aktie der…

DAX bleibt oben - Bayer, Commerzbank, Infineon, Merck, SAP und Siemens Energy im Check

Der Bayer-Schock hat dem DAX zum Wochenauftakt kaum etwas anhaben können. Das Minus gestern bedeutet zwar minus 100 Indexpunkte, doch…

DAX bleibt oben – Bayer, Commerzbank, Infineon, Merck, SAP und Siemens Energy im Check

Der Bayer-Schock hat dem DAX zum Wochenauftakt kaum etwas anhaben können. Das Minus gestern bedeutet zwar minus 100 Indexpunkte, doch…

Merck: 220 oder 166 Euro? Alle Kursziele und Ratings nach Q3-Zahlen auf einen Blick - Aktiennews

Darmstadt (www.aktiencheck.de) - Welche Kursziele und Ratings trauen die Analysten der führenden Banken und Research-Häuser der Merck-Aktie (ISIN: DE0006599905, WKN:…

Viele Unternehmen unterstützen Familienplanung

Fruchtbarkeitsbehandlungen, Zuschüsse zur Kinderbetreuung und Adoption, eingefrorene Eizellen: Immer mehr Unternehmen unterstützen ihre Mitarbeitenden bei familiären Aspekten. So greift das…

US FDA panel votes against Mercks chronic cough drug By Reuters

US FDA panel votes against Mercks chronic cough drug…

Merck’s Keytruda combo wins FDA approval for gastric cancer

Merck & Co Inc (NYSE:MRK) announced on Thursday that its anti-PD-1 therapy Keytruda in combination with chemotherapy has been approved…

Pharma Stock Roundup: FDA Okays AZNs Capivasertib & MRKs Keytruda Expanded Use

FDA approves AstraZenecas (AZN) new breast cancer drug, Truqap, and the expanded use of Mercks (MRK) Keytruda in a gastric…

Merck (MRK) Gets FDA Nod for Keytruda Expansion in Gastric Cancer

Following this approval, Mercks (MRK) Keytruda is approved for seven gastrointestinal cancers. Overall, the drug is approved for 38 indications…

: Merck’s Keytruda gets approval to treat certain types of gastric cancer

Merck MRK said late Thursday that the Food and Drug Administration has approved its star cancer drug Keytruda as treatment…

Merck & Co., Inc. (MRK) Presents at Jefferies London Healthcare Conference (Transcript)

…

FDA reviewers reportedly question efficacy of Merck cough drug

…

Intratumoral Cancer Therapies Market to Observe Stupendous Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Players - Nanobiotix, Sirnaomics, Apexigen, Replimune, Merck, OncoSec, DNAtrix, Treovir Istari

The dynamics of the intratumoral cancer therapies market are anticipated to change in the coming years owing to the approval…

US FDA staff flags concerns on Mercks chronic cough drug By Reuters

US FDA staff flags concerns on Mercks chronic cough drug…

Cell Expansion Market Size, Share & Trends Analysis Report 2023-2030, Featuring Profiles of Thermo Fisher Scientific, GE Healthcare, Corning, Merck, Sartorius and More

Dublin, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The "Cell Expansion Market Size, Share & Trends Analysis Report By…

JEFFERIES stuft MERCK KGAA auf Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Merck KGaA nach einem Gespräch mit dem Chef…

Ashland Board appoints Sanat Chattopadhyay, executive vice president, Merck & Company, as new director effective November 13, 2023

WILMINGTON, Del., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has announced the appointment of Sanat…

dpa-AFX ProFeed